Back

Phase Ib study of intravenous HRS-9057, an arginine vasopressin V2 receptor antagonist, versus oral tolvaptan in congestive heart failure with volume overload despite prior diuretic therapy

31 August 2026 (12:00 - 12:10)
Organised by: Logo
Congress Presentation Part of: Transforming heart failure with next-generation therapies and mechanisms Pharmacotherapy ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Wenchao Ou

(China)

4 More presentations in this session

Presentation thumbnail
Comparative effectiveness of finerenone versus spironolactone in patients hospitalized with heart failure: a prospective cohort study
Doctor R. Xiao (Chongqing, CN)
Abstract Slides Video
Presentation thumbnail
Optimizing mineralocorticoid receptor antagonist therapy with sodium zirconium cyclosilicate in heart failure
Doctor C. Basic (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
The effect of quality of life on all cause mortality in tafamidis treated vs. placebo ATTR-CM patients: post hoc analyses from the ATTR-ACT study
Doctor F. Cappelli (Florence, IT)
Abstract Slides Video
Presentation thumbnail
Pyruvate metabolism enzyme Dlat induces mitochondria protein hyperacetylation to limit fatty acid oxidation in the HFpEF heart
Doctor Y. Wang (CN)
Abstract Slides Video

Access the full session

Session thumbnail
Transforming heart failure with next-generation therapies and mechanisms
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 12:00 CET
You may be interested in
thumbnail
Congress Session
Late breaking clinical trials: medical therapy
11 May 2024
thumbnail
Congress Presentation
Safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-1893 in patients with obstructive hypertrophic cardiomyopathy: a randomized, double-blind, placebo-controlled phase 1 trial
29 August 2025
thumbnail
Congress Presentation
Role of SGLT2I in improving right ventricular systolic function in patients with HFpEF
28 August 2026
thumbnail
Congress Session
Advances in heart failure detection and therapy
10 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources